Therapeutic Monitoring of Infliximab and Adalimumab
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Infliximab;   Drug: Adalimumab Sponsor:   IRCCS Burlo Garofolo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Application of N-of-1 Rheumatoid Arthritis
Condition:   Arthritis, Rheumatoid Interventions:   Drug: Adalimumab;   Drug: Sarilumab;   Drug: Upadacitinib Sponsor:   Tufts Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials